Glypican-3 (GPC3) targeted Fe3O4 core/Au shell nanocomplex for fluorescence/MRI/photoacoustic imaging-guided tumor photothermal therapy

2019 ◽  
Vol 7 (12) ◽  
pp. 5258-5269 ◽  
Author(s):  
Rui Tian ◽  
Lei Zhu ◽  
Zainen Qin ◽  
Guohao Wang ◽  
Jingjing Wang ◽  
...  

PA/FI/MRI imaging guided Glypican-3 targeted hepatocellular carcinoma photothermal therapy mediated by Fe3O4 Core/Au shell nanocomplex.

2019 ◽  
Vol 7 (8) ◽  
pp. 3165-3177 ◽  
Author(s):  
Qingshan Chen ◽  
Jingqin Chen ◽  
Mu He ◽  
Yuanyuan Bai ◽  
Huixiang Yan ◽  
...  

The NIR-II PA and PTT nanoparticle based on the IR-1061 dye would benefit early diagnosis and treatment of HCC.


2021 ◽  
Vol 4 (2) ◽  
pp. 2019-2029
Author(s):  
Li-Peng Zhang ◽  
Lin Kang ◽  
Xianqiang Li ◽  
Shiyang Liu ◽  
Tianlong Liu ◽  
...  

2014 ◽  
Vol 26 (48) ◽  
pp. 8210-8216 ◽  
Author(s):  
Mei Chen ◽  
Shaoheng Tang ◽  
Zhide Guo ◽  
Xiaoyong Wang ◽  
Shiguang Mo ◽  
...  

2021 ◽  
pp. 2104650
Author(s):  
Chao Yin ◽  
Xiaozhen Li ◽  
Yi Wang ◽  
Yuying Liang ◽  
Shan Zhou ◽  
...  

Author(s):  
Qi Xu ◽  
Qiuting Li ◽  
Zhe Yang ◽  
Piao Huang ◽  
Han Hu ◽  
...  

Lenvatinib (LT) is gradually replacing sorafenib as an alternative targeted drug for advanced hepatocellular carcinoma (HCC). However, the anticancer effect of LT is still limited by low cytotoxicity, multidrug resistance...


2017 ◽  
Vol 129 (44) ◽  
pp. 13872-13876 ◽  
Author(s):  
Dong Yun Lee ◽  
Jin Yong Kim ◽  
Yonghyun Lee ◽  
Soyoung Lee ◽  
Wenjun Miao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document